summari report sale result
repres pro forma pf growth excl alr top-lin
result came consensu
estim respect report adjust ep
penni consensu estim
note modest benefit stj batteri recal
made easier prior year comp time impact
channel restock
epd establish pharmaceut
divis businessabt top-lin perform best
recal recent memori manag said organ growth would
still adjust aforement item
call guid organ sale growth excl alr
amo ahead previou estim
addit provid initi adj ep guidanc
bracket consensu previou
estim abt outlook repres ep growth
midpoint regard impact tax reform
expect tax rate compar
previou estim could potenti
benefit ep lower expect rate suspect
elect reinvest major potenti upsid base
manag commentari rais sale estim
estim
rais adj ep estim
estim rais price target
base adj ep estim
adj ep penni consensu forecast
rel model slight ep beat reflect higher
total revenu partli off-set lower gross margin vs
estim total revenu pf excl alr
beat consensu estim
respect growth improv across
segment nutrit sale growth improv sequenti
ex-fx vs behind strong adult nutrit
sale world-wide improv pediatr nutrit ou epd
sale grew doubl digit ex-fx behind
doubl digit growth china india latin america diagnost
growth ex-fx exclud alr sequenti
improv accord segment grew
faster market behind strong perform key core
laboratori molecular point-of-car poc geographi medic
devic growth acceler ex-fx vs
electrophysiolog ep structur heart neuromodul
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort intang ep continu
oper ep includ stj amo alr deal
forecast includ stj acquisit alr deal amo divestitur
compani prioriti stock list
compani data secur llc estim reuter
top-lin outlook ahead expect today call provid
guidanc compani expect organ sale growth came previou
estim import note guidanc exclud impact alr acquisit
amo divestitur regard fx manag expect report sale tailwind littl
driven strengthen euro segment wise nutrit expect grow low-singl
digit current model ex-fx diagnost expect grow mid high-singl digit
model ex-fx ex-alr epd expect grow high-singl digit model ex-
fx med devic expect grow mid high-singl digit model ex-fx
move full-year gross margin expect somewhat compar
gross margin note underli improv gross margin
somewhat mask due reclassif approxim net pension-rel
incomewhich report non-oper incom manag expect sg spend
sale respect regard tax rate expect tax
rate reflect impact tax reform bottom-lin guid
adj ep bracket consensu previou estim
recap guidanc manag guid organ growth full-year
guidanc bracket previou estim look abt guidanc busi
epd expect grow high-singl digit nutrit expect grow low-singl digit
diagnost expect grow mid-singl digit med devic expect grow mid high-singl
digit manag expect fx posit impact sale current rate
bottom-lin guid adjust ep compar previou estim
consensu
 corpor tax reform meaning posit first time publicli provid
thought impact corpor tax reform tax rate perspect compani
expect tax rate less previou estim
illustr purpos reduct tax rate result increment
ep use model manag said ep guidanc reflect flow-through bottom-lin
also note signific amount upsid reinvest sg given
compani mani on-going product launch obviou posit tax bill
unfett access provid ou cash base manag commentari expect
primari focu remain pay gross debt accumul financ stj alr
deal wed note compani paid debt earlier month manag expect finish
year debt balanc sheet although unlik see larg
acquisit would surpris compani pursu smaller tuck-in deal
increment updat alr manag provid addit color regard alr call
pictur said pleas integr alr busi synergi goal remain track
wed note provid formal updat regard alr accret targetsleav us believ
goalpost unchang alr contribut sale ahead
expect behind rampant flu season expect alr sale littl
mention contribut alr exclud abt top-lin
guidanc remain optimist long-term prospect alr manag said
develop pipelin turnaround busi longer process stj
price target
price target base ep estim risk target includ
slower growth key busi market delay stj alr integr slower margin
expect continu deliv double-digit underli ep growth mid-singl digit underli
sale growth oper leverag
abbott laboratori diversifi global medic product compani four key busi segment
nutrit diagnost establish pharmaceut epd medic devic compani report
total revenu compani acquir stj januari nearli doubl
 incom statement million except per share forma stj alr amo good sold fit fit includ includ med-tech ex-medtech fit fit includ expens fx loss expens ep continu ep includ discontinu analysiscost good margin margin fit fit compani report secur llc estim medic technolog
